Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement
Status:
Terminated
Trial end date:
2018-11-13
Target enrollment:
Participant gender:
Summary
This is a phase 2 study to see how effective investigational drug, JNJ-42756493, is when
given in combination with dexamethasone in two groups of patients with multiple myeloma
(cancer of the plasma cells, a type of white blood cell present in bone marrow) that has
relapsed (has come back after a period of improvement) or refractory (did not respond to
standard treatment).